Jpmorgan Chase & CO Journey Medical Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Journey Medical Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 469 shares of DERM stock, worth $2,602. This represents 0.0% of its overall portfolio holdings.
Number of Shares
469
Previous 20
2245.0%
Holding current value
$2,602
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DERM
# of Institutions
40Shares Held
2.94MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.8 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.8 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.75 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.49 Million0.0% of portfolio
-
American Financial Group Inc180KShares$999,0000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $64.4M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...